ASX / MEDIA RELEASE Morgans Initiates Research Coverage Brisbane, Australia, 10 July 2017 -- ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that Morgans Financial Limited has initiated research coverage of the company.

The full report can be seen on ResApp's website at https://www.resapphealth.com.au/investor-relations/analyst-coverage/

About ResApp Health Limited

ResApp Health Limited (ASX: RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware. The algorithms were initially developed by The University of Queensland with funding from the Bill and Melinda Gates Foundation. ResApp has adult and paediatric clinical studies underway at leading US and Australian hospitals with results demonstrating accurate diagnosis of pneumonia, asthma/reactive airways disease, bronchiolitis, croup and upper respiratory tract infections in children as well as chronic obstructive pulmonary disease, asthma, pneumonia and upper respiratory tract infections in adults. Potential customers of ResApp's products include healthcare providers in telehealth, emergency department, urgent care and primary care settings as well as global aid and humanitarian organisations in the developing world.

For more information on ResApp, visit www.resapphealth.com.au

Contacts

Dr Tony Keating

CEO and Managing Director

+61 430 180 659

tony@resapphealth.com.au

Mr Brian Leedman Executive Director and

Vice President, Corporate Affairs

+61 412 281 780

brian@resapphealth.com.au

ResApp Health Limited ABN 51 094 468 318

Headquarters: Level 8, 127 Creek St, Brisbane QLD 4000 Australia Registered Office: Level 22, 44 St Georges Tce, Perth WA 6000 Australia

T +61 8 6211 5099 E info@resapphealth.com.au W www.resapphealth.com.au

ResApp Health Limited published this content on 10 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 09 July 2017 23:10:05 UTC.

Original documenthttps://www.resapphealth.com.au/wp-content/uploads/2017/07/170710-Morgans.pdf

Public permalinkhttp://www.publicnow.com/view/B2F77716B7F4FFC066EF3E1D799113E331F36545